awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35141906-67EBC470-8291-4841-BA58-9C5E6E7C175A
Q35141906-67EBC470-8291-4841-BA58-9C5E6E7C175A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35141906-67EBC470-8291-4841-BA58-9C5E6E7C175A
Brivanib attenuates hepatic fibrosis in vivo and stellate cell activation in vitro by inhibition of FGF, VEGF and PDGF signaling.
P2860
Q35141906-67EBC470-8291-4841-BA58-9C5E6E7C175A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35141906-67EBC470-8291-4841-BA58-9C5E6E7C175A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aaf66604e4bc6f45414b785db04b4f7ed74b2978
P2860
Phase II, open-label study of brivanib as second-line therapy in patients with advanced hepatocellular carcinoma.